簡(jiǎn)要描述:聚磷酸肌醇磷酸酶4A抗體免 疫 原;KLH conjugated synthetic peptide derived from human INPP4A: 151-250/977
產(chǎn)品分類
Product Category相關(guān)文章
Related Articles詳細(xì)介紹
聚磷酸肌醇磷酸酶4A抗體
產(chǎn)品名稱 | 英文名稱 | 貨號(hào) |
聚磷酸肌醇磷酸酶4A抗體 | INPP4A | GOY-01K0480 |
商品屬性:
英文名稱: INPP4A
中文名:聚磷酸肌醇磷酸酶4A抗體
別 名;Type I
4-phosphatase; 107kDa; 4-bisphosphate 4-phosphatase; 9630012D15; D130048C09Rik;
Inositol polyphosphate 4 phosphatase type I 107kDa; Inositol polyphosphate 4
phosphatase type I; Inositol polyphosphate 4-phosphatase type I; INP4A_HUMAN;
INPP4; Inpp4a; OTTHUMP00000203138; OTTHUMP00000203139; OTTHUMP00000203141;
OTTHUMP00000225217; R74740; TVAS1; Type I inositol 3 4 bisphosphate 4
phosphatase; Type I inositol 3,4 bisphosphate 4 phosphatase; Type I inositol-3.
研究領(lǐng)域;細(xì)胞生物 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo)
抗體來源;Rabbit
克隆類型;Polyclonal
交叉反應(yīng);(predicted:
Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, )
產(chǎn)品應(yīng)用;WB=1:500-2000
ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復(fù))
not yet tested in
other applications.
optimal
dilutions/concentrations should be determined by the end user.
理論分子量;110kDa
細(xì)胞定位;細(xì)胞漿
性 狀;Liquid
濃 度;1mg/ml
免 疫 原;KLH
conjugated synthetic peptide derived from human INPP4A: 151-250/977
亞 型;IgG
純化方法;affinity
purified by Protein A
緩 沖 液;0.01M
TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
注意事項(xiàng);This
product as supplied is intended for research use only, not for use in human,
therapeutic or diagnostic applications.
產(chǎn)品介紹:
The inositol polyphosphate 4-phosphatases
selectively remove the phosphate from the 4-position of various phosphatidylinositols,
which generate second messengers in response to extracellular signals. Both
the type I and type II 4-phosphatases catalyze the hydrolysis of
phosphatidylinositol 3,4-bisphosphate, inositol 1,3,4-trisphosphate, and
inositol 3,4-bisphosphate. Type I and type II 4-phosphatases are both
alternatively spliced into two isoforms, a and b, which have been detected in
human platelets, rat brain, heart, skeletal muscle and spleen; and all
isoforms contain a conserved motif CKSAKDRT, which contains the active site
consensus sequence C-X5-R. Both type I and II 4-phosphatases are thought to
regulate the level of intracellular calcium by acting as signal terminating
enzymes. Catalyzes the hydrolysis of the 4-position
phosphate of phosphatidylinositol 3,4-bisphosphate, inositol
1,3,4-trisphosphate and inositol 3,4-bisphosphate. |
多克隆抗體制備:
我公司合成抗原,保證陽性血清和抗體ELISA效價(jià)達(dá)到1:32000,由蛋白抗原制備的多抗,保證WB檢測(cè)結(jié)果是陽性。技術(shù)服務(wù)實(shí)行分步報(bào)價(jià),按節(jié)點(diǎn)收費(fèi),為客戶節(jié)約成本。
鼠單克隆抗體制備:
客戶可根據(jù)項(xiàng)目實(shí)際需求情況靈活選擇進(jìn)行,我公司將為您的項(xiàng)目提供專業(yè)的建議。在制備過程中,與客戶互動(dòng)驗(yàn)證,確保最終制備的抗體ELISA陽性血清檢測(cè)達(dá)到合同要求的同時(shí),也能滿足客戶抗體最終應(yīng)用驗(yàn)證需求。技術(shù)服務(wù)實(shí)行分步報(bào)價(jià),按節(jié)點(diǎn)收費(fèi),為客戶節(jié)約成本。
重組抗體表達(dá)服務(wù):
重組抗體技術(shù)使制備人源化抗體和人源抗體成為可能,而這是其他常規(guī)的多克隆或單克隆抗體制備方法無法做到的。我公司已搭建好的抗體測(cè)序、重組抗體表達(dá)等先進(jìn)平臺(tái),能為客戶提供各種類型的重組抗體表達(dá)服務(wù),包含鼠源單克隆抗體構(gòu)建及表達(dá)、更換恒定區(qū)亞型的嵌合抗體表達(dá),抗體人源化改造及表達(dá)等服務(wù)。
單項(xiàng)免疫學(xué)及檢測(cè)服務(wù):
我公司也為客戶提供單項(xiàng)免疫學(xué)和檢測(cè)服務(wù),如動(dòng)物免疫、動(dòng)物飼養(yǎng)、抗體修飾服務(wù)(如FITC,HRP等的標(biāo)記)、以及ELISA,WB,IHC,DB等檢測(cè)服務(wù)。
抗體定制服務(wù):
已注冊(cè)商標(biāo),主要用于抗體藥物發(fā)現(xiàn)和開發(fā),是我公司針對(duì)有特定應(yīng)用要求和各種模型測(cè)試的客戶量身定制的專業(yè)服務(wù),主要面向工業(yè)客戶。
產(chǎn)品咨詢
歡迎您關(guān)注我們的微信了解更多信息
電話
微信掃一掃